25 May 2013
Keywords: par, begin, shipping, clonazepam, odt, pharmaceutical, announced
Article | 15 August 2005
Par Pharmaceutical has announced that its wholly-owned subsidiary, Kali Laboratories, has received final approval from the US Food and Drug
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 August 2005
24 May 2013
© 2013 thepharmaletter.com